The impact of first-trimester serum free β-human chorionic gonadotropin and pregnancy-associated plasma protein A on the diagnosis of fetal growth restriction and small for gestational age infant

Fetal Diagnosis and Therapy

Volumn 25, Issue 1, 2009, Pages 130-135

  Montanari, Laura ^a   Alfei, Alessandro ^a   Albonico, Giulia ^a   Moratti, Remigio ^a   Arossa, Alessia ^a   Beneventi, Fausta ^a   Spinillo, Arsenio ^a  

^a UNIVERSITY OF PAVIA   (Italy)

Author keywords

Fetal growth restriction; Preeclampsia; Pregnancy associated plasma protein A

Indexed keywords

CHORIONIC GONADOTROPIN BETA SUBUNIT; PREGNANCY ASSOCIATED PLASMA PROTEIN A;

ADULT; ARTICLE; BIRTH WEIGHT; BODY MASS; CLINICAL EVALUATION; CONTROLLED STUDY; DOPPLER FLOWMETRY; FEMALE; FETUS ECHOGRAPHY; FIRST TRIMESTER PREGNANCY; GESTATIONAL AGE; GROWTH CURVE; HORMONE BLOOD LEVEL; HUMAN; INFANT; INTRAUTERINE GROWTH RETARDATION; LOGISTIC REGRESSION ANALYSIS; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; NUCHAL TRANSLUCENCY MEASUREMENT; PLACENTA PERFUSION; PREECLAMPSIA; PREGNANCY OUTCOME; PREMATURITY; PRENATAL DIAGNOSIS; PREVALENCE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; SMALL FOR DATE INFANT; SOLUTIO PLACENTAE;

CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN; FEMALE; FETAL GROWTH RETARDATION; HUMANS; INFANT, NEWBORN; INFANT, SMALL FOR GESTATIONAL AGE; LONGITUDINAL STUDIES; NUCHAL TRANSLUCENCY MEASUREMENT; PREGNANCY; PREGNANCY OUTCOME; PREGNANCY TRIMESTER, FIRST; PREGNANCY-ASSOCIATED PLASMA PROTEIN-A; PRENATAL DIAGNOSIS;

EID: 61849132166     PISSN: 10153837     EISSN: None     Source Type: Journal    
DOI: 10.1159/000207554     Document Type: Article

References (20)

1. Spencer K, Cowans NJ, Avgidou K, Molina F, Nicolaides KH: First-trimester biochemical markers of aneuploidy and the prediction of small-for-gestational age fetuses. Ultrasound Obstet Gynecol 2008; 31: 15-19. (Pubitemid 351211925)
2. Driscoll DA, Gross SJ; Professional Practice and Guidelines Committee: First trimester diagnosis and screening for fetal aneuploidy. Genet Med 2008; 10: 73-75.
3. Dugoff L, Hobbins JC, Malone FD, Porter TF, Luthy D, Comstock CH, Hankins G, Berkowitz RL, Merkatz I, Craigo SD, Timor-Tritsch IE, Carr SR, Wolfe HM, Vidaver J, D'Alton ME; FASTER Trial Research Consortium: First-trimester maternal serum PAPP-A and free-beta subunit human chorionic gonadotropin concentrations and nuchal translucency are associated with obstetric complications: a population-based screening study (the FASTER trial). Am J Obstet Gynecol 2004; 191: 1446-1451. (Pubitemid 39421612)
4. Krantz D, Goetzl L, Simpson JL, Thom E, Zachary J, Hallahan TW, Silver R, Pergament E, Platt LD, Filkins K, Johnson A, Mahoney M, Hogge WA, Wilson RD, Mohide P, Hershey D, Wapner R; First Trimester Maternal Serum Biochemistry and Fetal Nuchal Translucency Screening (BUN) Study Group: Association of extreme first-trimester free human chorionic gonadotropin, pregnancy-associated plasma protein A, and nuchal translucency with intrauterine growth restriction and other adverse pregnancy outcomes. Am J Obstet Gynecol 2004; 191: 1452-1458. (Pubitemid 39421613)
5. Spencer K, Cowans NJ, Molina F, Kagan KO, Nicolaides KH: First-trimester ultrasound and biochemical markers of aneuploidy and the prediction of preterm or early preterm delivery. Ultrasound Obstet Gynecol 2008; 31: 147-152. (Pubitemid 351211925)
6. Barrett SL, Bower C, Hadlow NC: Use of the combined first-trimester screen result and low PAPP-A to predict risk of adverse fetal outcomes. Prenat Diagn 2008; 28: 28-35. (Pubitemid 351251986)
7. Boldt HB, Conover CA: Pregnancy-associated plasma protein-A (PAPP-A): a local regulator of IGF bioavailability through cleavage of IGFBPs. Growth Horm IGF Res 2007; 17: 10-18.
8. Yaron Y, Ochshorn Y, Heifetz S, Lehavi O, Sapir Y, Orr-Urtreger A: First trimester maternal serum free human chorionic gonadotropin as a predictor of adverse pregnancy outcome. Fetal Diagn Ther 2002; 17: 352-356. (Pubitemid 36160157)
9. Smith GC, Shah I, Crossley JA, Aitken DA, Pell JP, Nelson SM, Cameron AD, Connor MJ, Dobbie R: Pregnancy-associated plasma protein A and α-fetoprotein and prediction of adverse perinatal outcome. Obstet Gynecol 2006; 107: 161-166. (Pubitemid 43755518)
10. Peterson SE, Simhan NH: First-trimester pregnancy-associated plasma protein A and subsequent abnormalities of fetal growth. Am J Obstet Gynecol 2008;doi:10.1016/j. ajog.2007.12.026.
11. Resnik R: Intrauterine growth restriction. Obstet Gynecol 2002; 99: 490-496.
12. Bukowski R: Fetal growth potential and pregnancy outcome. Semin Perinatol 2004;28: 51-58. (Pubitemid 38298829)
13. Davey DA, McGillivray IM: The classification and definition of the hypertensive disorders of pregnancy. Am J Obstet Gynecol 1988; 158: 892-898. (Pubitemid 18106884)
14. Parazzini F, Cortinovis I, Bortolus R, Fedele L: Standard di peso alla nascita in Italia. Ann Ost Gin Med Perin 1991; 112: 203-246.
15. Todros T, Ferrazzi E, Groli C, Nicolini U, Parodi L, Pavoni M, Zorzoli A, Zucca S: Fitting growth curves to head and abdomen measurements of the fetuses: a multicenter study. J Clin Ultrasound 1987; 15: 95-105. (Pubitemid 17004882)
16. Arduini D, Rizzo G, Mancuso S, Romanini C: Longitudinal assessment of blood flow velocity waveform in the healthy human fetus. Prenat Diagn 1987; 7: 613-617. (Pubitemid 17166876)
17. Canini S, Prefumo F, Pastorino D, Crocetti L, Afflitto CG, Venturini PL, De Blasio P: Association between birth weight and firsttrimester free β-human chorionic gonadotropin and pregnancy-associated plasma protein A. Fertil Steril 2008; 89: 174-178.
18. Leung TY, Chan LW, Leung TN, Fung TY, Sahota DS, Lau TK: First-trimester maternal serum levels of placental hormones are independent predictors of second-trimester fetal growth parameters. Ultrasound Obstet Gynecol 2006; 27: 156-161.
19. Cowans NJ, Spencer K: First-trimester ADAM12 and PAPP-A as markers for intrauterine fetal growth restriction through their roles in the insulin-like growth factor system. Prenat Diagn 2007; 27: 264-271.
20. Pilalis A, Souka AP, Antsaklis P, Daskalakis G, Papantoniou N, Mesogitis S, Antsaklis A: Screening for pre-eclampsia and fetal growth restriction by uterine artery Doppler and PAPP-A at 11-14 weeks' gestation. Ultrasound Obstet Gynecol 2007; 29: 135-140. (Pubitemid 46326584)